The Anti-Red Tape Authority (ARTA) is expediting permit applications for potential COVID-19 vaccine manufacturers in the Philippines by establishing a 'green lane' for faster processing.
ARTA plans to meet with the Department of Health (DOH), the Food and Drug Administration (FDA), the Department of Trade and Industry (DTI), and the Securities and Exchange Commission (SEC) to streamline processes.
Four firms, United Laboratories (Unilab), Glovax Biologics Corp., IG/IP Biotech, and Dr. Zen Biotech Inc., have committed to comply with requirements and requested the green lane.
ARTA aims to attract local companies to invest in vaccine production within the country by eliminating red tape.
DTI Secretary Ramon M. Lopez reported these commitments to President Rodrigo Duterte.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.



